VIEMED HEALTHCARE INC (VMD) Stock Fundamental Analysis
NASDAQ:VMD - Nasdaq - CA92663R1055 - Common Stock - Currency: USD
We assign a fundamental rating of 6 out of 10 to VMD. VMD was compared to 103 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of VMD get a neutral evaluation. Nothing too spectacular is happening here. VMD is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make VMD a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
VMD had positive earnings in the past year.
In the past year VMD had a positive cash flow from operations.
In the past 5 years VMD has always been profitable.
In the past 5 years VMD always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of VMD (6.90%) is better than 85.44% of its industry peers.
VMD's Return On Equity of 9.12% is fine compared to the rest of the industry. VMD outperforms 71.84% of its industry peers.
VMD has a better Return On Invested Capital (7.48%) than 73.79% of its industry peers.
The Average Return On Invested Capital over the past 3 years for VMD is below the industry average of 9.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.9% | ||
| ROE | 9.12% | ||
| ROIC | 7.48% |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
1.3 Margins
With a decent Profit Margin value of 5.28%, VMD is doing good in the industry, outperforming 77.67% of the companies in the same industry.
VMD's Profit Margin has declined in the last couple of years.
The Operating Margin of VMD (6.47%) is better than 66.99% of its industry peers.
In the last couple of years the Operating Margin of VMD has declined.
Looking at the Gross Margin, with a value of 58.71%, VMD belongs to the top of the industry, outperforming 80.58% of the companies in the same industry.
In the last couple of years the Gross Margin of VMD has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.47% | ||
| PM (TTM) | 5.28% | ||
| GM | 58.71% |
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VMD is destroying value.
VMD has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, VMD has more shares outstanding
The debt/assets ratio for VMD has been reduced compared to a year ago.
2.2 Solvency
VMD has an Altman-Z score of 6.30. This indicates that VMD is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.30, VMD belongs to the best of the industry, outperforming 87.38% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that VMD is not too dependend on debt financing.
VMD has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. VMD outperforms 80.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.3 |
ROIC/WACC0.83
WACC9.04%
2.3 Liquidity
A Current Ratio of 1.38 indicates that VMD should not have too much problems paying its short term obligations.
With a Current ratio value of 1.38, VMD perfoms like the industry average, outperforming 44.66% of the companies in the same industry.
A Quick Ratio of 1.26 indicates that VMD should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.26, VMD is in line with its industry, outperforming 44.66% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.38 | ||
| Quick Ratio | 1.26 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 15.38% over the past year.
The Earnings Per Share has been growing slightly by 4.01% on average over the past years.
The Revenue has grown by 19.97% in the past year. This is quite good.
VMD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.80% yearly.
EPS 1Y (TTM)15.38%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%50%
Revenue 1Y (TTM)19.97%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%16.87%
3.2 Future
Based on estimates for the next years, VMD will show a very strong growth in Earnings Per Share. The EPS will grow by 31.47% on average per year.
VMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.97% yearly.
EPS Next Y33.46%
EPS Next 2Y42.13%
EPS Next 3Y31.47%
EPS Next 5YN/A
Revenue Next Year16.47%
Revenue Next 2Y14.66%
Revenue Next 3Y11.97%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 23.83, the valuation of VMD can be described as rather expensive.
Based on the Price/Earnings ratio, VMD is valued a bit cheaper than 64.08% of the companies in the same industry.
VMD's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.45.
The Price/Forward Earnings ratio is 12.64, which indicates a correct valuation of VMD.
Based on the Price/Forward Earnings ratio, VMD is valued cheaply inside the industry as 81.55% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of VMD to the average of the S&P500 Index (21.90), we can say VMD is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.83 | ||
| Fwd PE | 12.64 |
4.2 Price Multiples
VMD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VMD is cheaper than 85.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 6.78 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
VMD has a very decent profitability rating, which may justify a higher PE ratio.
VMD's earnings are expected to grow with 31.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.71
PEG (5Y)5.94
EPS Next 2Y42.13%
EPS Next 3Y31.47%
5. Dividend
5.1 Amount
VMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.15
+0.07 (+0.99%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners64.91%
Inst Owner ChangeN/A
Ins Owners12.97%
Ins Owner Change14.41%
Market Cap282.57M
Analysts80
Price Target13.26 (85.45%)
Short Float %1.14%
Short Ratio2.06
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.35%
Min EPS beat(2)-5.7%
Max EPS beat(2)-0.99%
EPS beat(4)1
Avg EPS beat(4)-4.53%
Min EPS beat(4)-43.42%
Max EPS beat(4)32.01%
EPS beat(8)2
Avg EPS beat(8)-9.01%
EPS beat(12)3
Avg EPS beat(12)-11.79%
EPS beat(16)5
Avg EPS beat(16)-5.78%
Revenue beat(2)1
Avg Revenue beat(2)-1.58%
Min Revenue beat(2)-3.39%
Max Revenue beat(2)0.24%
Revenue beat(4)3
Avg Revenue beat(4)-0.38%
Min Revenue beat(4)-3.39%
Max Revenue beat(4)1.15%
Revenue beat(8)6
Avg Revenue beat(8)0.15%
Revenue beat(12)9
Avg Revenue beat(12)0.31%
Revenue beat(16)12
Avg Revenue beat(16)1.02%
PT rev (1m)1.3%
PT rev (3m)1.3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.88%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.83 | ||
| Fwd PE | 12.64 | ||
| P/S | 1.21 | ||
| P/FCF | N/A | ||
| P/OCF | 6.93 | ||
| P/B | 2.1 | ||
| P/tB | 2.8 | ||
| EV/EBITDA | 6.78 |
EPS(TTM)0.3
EY4.2%
EPS(NY)0.57
Fwd EY7.91%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)1.03
OCFY14.43%
SpS5.89
BVpS3.41
TBVpS2.55
PEG (NY)0.71
PEG (5Y)5.94
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.9% | ||
| ROE | 9.12% | ||
| ROCE | 10.56% | ||
| ROIC | 7.48% | ||
| ROICexc | 8.05% | ||
| ROICexgc | 10.81% | ||
| OM | 6.47% | ||
| PM (TTM) | 5.28% | ||
| GM | 58.71% | ||
| FCFM | N/A |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
ROICexc(3y)8.81%
ROICexc(5y)13.58%
ROICexgc(3y)11.22%
ROICexgc(5y)15.03%
ROCE(3y)10.8%
ROCE(5y)14.35%
ROICexcg growth 3Y2.65%
ROICexcg growth 5Y-2.94%
ROICexc growth 3Y-7.87%
ROICexc growth 5Y-9.04%
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
F-Score8
Asset Turnover1.31
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.09 | ||
| Cap/Depr | 183.87% | ||
| Cap/Sales | 20.3% | ||
| Interest Coverage | 17.69 | ||
| Cash Conversion | 100.05% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.38 | ||
| Quick Ratio | 1.26 | ||
| Altman-Z | 6.3 |
F-Score8
WACC9.04%
ROIC/WACC0.83
Cap/Depr(3y)138.25%
Cap/Depr(5y)145.08%
Cap/Sales(3y)15.87%
Cap/Sales(5y)14.88%
Profit Quality(3y)92.19%
Profit Quality(5y)75.37%
High Growth Momentum
Growth
EPS 1Y (TTM)15.38%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%50%
EPS Next Y33.46%
EPS Next 2Y42.13%
EPS Next 3Y31.47%
EPS Next 5YN/A
Revenue 1Y (TTM)19.97%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%16.87%
Revenue Next Year16.47%
Revenue Next 2Y14.66%
Revenue Next 3Y11.97%
Revenue Next 5YN/A
EBIT growth 1Y-2.82%
EBIT growth 3Y10.05%
EBIT growth 5Y11.94%
EBIT Next Year209.91%
EBIT Next 3Y61.39%
EBIT Next 5YN/A
FCF growth 1Y-186.63%
FCF growth 3Y-21.74%
FCF growth 5Y-25.39%
OCF growth 1Y31.09%
OCF growth 3Y20.23%
OCF growth 5Y15.41%